HDAC6-IN-18
HDAC6-IN-18 (Compound 4) is a first irreversible HDAC6 isoform selective inhibitor with potent anti-multiple myeloma activity. HDAC6-IN-18 has HDAC6 inhibitory activity in RPMI8266, U266 and MM.1S cells with IC50 values of 0.17, 0.7 and 0.42 μM, respectively[1].
Product Specifications
UNSPSC
12352005
Target
HDAC
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hdac6-in-18.html
Solubility
10 mM in DMSO
Smiles
[O-][N+]1=C(C(OCC2=CC=C(C=C2)C(NO)=O)=NO1)S(=O)(C3=CC=CC=C3)=O
Molecular Formula
C16H13N3O7S
Molecular Weight
391.36
References & Citations
[1]Liu F, et al. Discovery of the First Irreversible HDAC6 Isoform Selective Inhibitor with Potent Anti-Multiple Myeloma Activity. J Med Chem. 2023 Jul 27;66 (14) :10080-10091.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6415336-01 0.1 mL
EGLN2 (Egl-9 Family Hypoxia-inducible Factor 2, EIT6, PHD1, HPH-1, HPH-3, HIFPH1, HIF-PH1) (MaxLight 405)
Sign In for Pricing
View Details MBS6415336-02 5x 0.1 mL
EGLN2 (Egl-9 Family Hypoxia-inducible Factor 2, EIT6, PHD1, HPH-1, HPH-3, HIFPH1, HIF-PH1) (MaxLight 405)
Sign In for Pricing
View Details 
MBS1880848-01 0.05 mg
Biotinylated Anti-ADAM9 (izeltabart biosimilar) mAb
Sign In for Pricing
View Details